Utilize high-fidelity, next-generation RNA-sequencing tailored specifically to identify critical transcriptional shifts in the conserved Longevity GRN (IIS, TOR, SKN-1/NRF2).
Creative Biolabs provides an advanced, mechanism-focused validation service for longevity-promoting compounds using the genetically tractable C. elegans model. We deliver a complete, high-resolution gene regulatory network (GRN) signature via deep RNA-sequencing and advanced bioinformatics modeling, definitively confirming your compound's mechanism of action (MoA) against the conserved human aging pathways. Our commitment is to provide customized, quality-controlled data that translates directly into de-risked and accelerated pipelines.
The longevity GRN controls how organisms manage fundamental stresses of aging, including poor mitochondrial function, oxidative damage, and declining insulin signaling. C. elegans possesses a highly conserved GRN (including human orthologs like DAF-16/FOXO and SKN-1/NRF2) that dictates lifespan. By analyzing the differential gene expression and network connectivity triggered by your compound, we can definitively validate its mechanistic action at the transcriptional level, providing superior scientific credibility compared to basic endpoint assays.
Explore our comprehensive service offerings and request a formal consultation.
Fig.1 DAF-16/FOXO is the central transcription factor promoting longevity in C. elegans. 1
Utilize high-fidelity, next-generation RNA-sequencing tailored specifically to identify critical transcriptional shifts in the conserved Longevity GRN (IIS, TOR, SKN-1/NRF2).
Leverage proprietary bioinformatics mapping to cross-reference C. elegans gene signatures against human orthologs, ensuring maximum translational relevance for your preclinical studies.
Employ Quality-by-Design (QbD) principles across all stages, from synchronized worm culture to validated data filtering, guaranteeing robust and reproducible results suitable for advanced data packages.
| Output Feature | Unique Advantage |
|---|---|
| Mitohormesis and Stress-Response Expertise | We validate the activation of critical survival pathways. Our analysis explicitly monitors gene signatures associated with mitohormesis (beneficial mitochondrial stress) and oxidative stress resistance (SKN-1/NRF2). |
| Non-Autonomous Regulation Validation | We are experts in distinguishing tissue-specific effects from systemic, non-autonomous regulation originating in the nervous system. |
| Causative Proof via RNAi | We bridge the gap between correlation and causation. Our optional RNAi-mediated functional validation step confirms the necessity of the identified GRN hub genes for your compound's effect. |
Leverage Creative Biolabs' decisive advantage by requesting a quotation.
A: Absolutely. The core longevity pathways, including Insulin/IGF-1 signaling (IIS), mTOR, and the NRF2/SKN-1 stress response, are highly conserved, sharing 60-80% homology with human genes. Our GRN analysis focuses exclusively on these evolutionarily conserved nodes, ensuring high translational relevance for your drug discovery program.
A: A standard assay provides a simple yes/no answer on lifespan extension. Our GRN service provides the why - the detailed, high-resolution transcriptional mechanism of action. This mechanistic data is what secures strong IP, derisks your pipeline from false positives, and validates your compound's impact on age-associated disease models.
For rapid, low-cost screening of compound activity on conserved longevity mechanisms like TOR and sirtuins, offering a complementary early-stage validation step.
Learn More →For late-stage pre-clinical validation, we offer robust lifespan and healthspan studies in rodent models, focusing on confirmation of the C. elegans-validated MoA in a mammalian system.
Learn More →Creative Biolabs' C. elegans model based longevity GRN validation service delivers the highest resolution, most defensible mechanistic data available in the field of aging research. To learn more about how our services can protect your intellectual property and accelerate your path to success, please contact us.
Reference